1. Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
   Kristie Bloom et al, 2018, Genes CrossRef
2. DNA methyltransferases in virus‐associated cancers
   Javad Charostad et al, 2019, Reviews in Medical Virology CrossRef
3. Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer Models
   Monica Rienzo et al, 2021, Frontiers in Oncology CrossRef
4. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
   Kurt Sartorius et al, 2020, Viruses CrossRef
5. Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
   Gang Xu et al, 2020, Cancer Cell International CrossRef
6. MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection
   Er-Lei Zhang et al, 2017, Oncology Letters CrossRef
7. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis
   null Sartorius et al, 2019, Cells CrossRef
8. Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review
   Enakshi Sivasudhan et al, 2022, Cells CrossRef
9. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma
   Liqiong Yang et al, 2022, Hepatology International CrossRef
10. Human PRDM2: Structure, function and pathophysiology
    A. Sorrentino et al, 2018, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
11. New Approaches to the Treatment of Chronic Hepatitis B
    Alexandra Alexopoulou et al, 2020, Journal of Clinical Medicine CrossRef
12. Hepatitis B virus x gene-downregulated growth-arrest specific 5 inhibits the cell viability and invasion of hepatocellular carcinoma cell lines by activating Y-box-binding protein 1/p21 signaling
    Xiaojun Yu et al, 2022, Journal of Cell Communication and Signaling CrossRef
13. Cell cycle kinases (AUKA, CDK1, PLK1) are prognostic biomarkers and correlated with tumor-infiltrating leukocytes in HBV related HCC
    Baitul Islam et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
14. The progress of molecules and strategies for the treatment of HBV infection
    Youlu Pan et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef
15. Combination of RIZ1 Overexpression and Radiotherapy Contributes to Apoptosis and DNA Damage of HeLa and SiHa Cervical Cancer Cells
    Shanshan Yang et al, 2018, Basic & Clinical Pharmacology & Toxicology CrossRef
16. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma
    Na Li et al, 2019, Therapeutic Advances in Gastroenterology CrossRef
17. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
    Kurt Sartorius et al, 2021, Frontiers in Immunology CrossRef
18. Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA
    Kristie Bloom et al, 2019, BMC Infectious Diseases CrossRef
19. DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis
    Sharon Kuss-Duerkop et al, 2018, Viruses CrossRef
20. Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC
    Tahereh Donyavi et al, 2021, International Immunopharmacology CrossRef
21. Multifaceted Role of PRDM Proteins in Human Cancer
    Amelia Casamassimi et al, 2020, International Journal of Molecular Sciences CrossRef
22. Epigenetic modulation in chronic hepatitis B virus infection
    Maura Dandri, 2020, Seminars in Immunopathology CrossRef